Form 8-K - Current report:
SEC Accession No. 0001628280-25-024444
Filing Date
2025-05-12
Accepted
2025-05-12 07:21:47
Documents
32
Period of Report
2025-05-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rmti-20250512.htm   iXBRL 8-K 33097
2 EX-99.1 a20250512rmtiinvestorpre.htm EX-99.1 5842
6 a20250512rmtiinvestorpre001.jpg GRAPHIC 147598
7 a20250512rmtiinvestorpre002.jpg GRAPHIC 182335
8 a20250512rmtiinvestorpre003.jpg GRAPHIC 138099
9 a20250512rmtiinvestorpre004.jpg GRAPHIC 123782
10 a20250512rmtiinvestorpre005.jpg GRAPHIC 73574
11 a20250512rmtiinvestorpre006.jpg GRAPHIC 133696
12 a20250512rmtiinvestorpre007.jpg GRAPHIC 86432
13 a20250512rmtiinvestorpre008.jpg GRAPHIC 118209
14 a20250512rmtiinvestorpre009.jpg GRAPHIC 98469
15 a20250512rmtiinvestorpre010.jpg GRAPHIC 120414
16 a20250512rmtiinvestorpre011.jpg GRAPHIC 114038
17 a20250512rmtiinvestorpre012.jpg GRAPHIC 54631
18 a20250512rmtiinvestorpre013.jpg GRAPHIC 91850
19 a20250512rmtiinvestorpre014.jpg GRAPHIC 75168
20 a20250512rmtiinvestorpre015.jpg GRAPHIC 112065
21 a20250512rmtiinvestorpre016.jpg GRAPHIC 93349
22 a20250512rmtiinvestorpre017.jpg GRAPHIC 98329
23 a20250512rmtiinvestorpre018.jpg GRAPHIC 118319
  Complete submission text file 0001628280-25-024444.txt   2891824

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rmti-20250512.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rmti-20250512_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rmti-20250512_pre.xml EX-101.PRE 12508
34 EXTRACTED XBRL INSTANCE DOCUMENT rmti-20250512_htm.xml XML 2708
Mailing Address 30142 WIXOM ROAD WIXOM MI 48393
Business Address 30142 WIXOM ROAD WIXOM MI 48393 8004493353
ROCKWELL MEDICAL, INC. (Filer) CIK: 0001041024 (see all company filings)

EIN.: 383317208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23661 | Film No.: 25932576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)